Yerim Hwang

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Electromagnetic field-inducible in vivo gene switch for remote spatiotemporal control of gene expression.

Electromagnetic field-inducible in vivo gene switch for remote spatiotemporal control of gene expression.

Journal: Cell
Published: June 29, 2026

Therapeutic Gene Editing of APOE4 in Sporadic Alzheimer's Disease via Prime Editor 7.

Therapeutic Gene Editing of APOE4 in Sporadic Alzheimer's Disease via Prime Editor 7.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 09, 2026

Cell-targeted nanocomplex facilitates direct reprogramming of astrocytes into dopaminergic neurons in Parkinson's disease.

Cell-targeted nanocomplex facilitates direct reprogramming of astrocytes into dopaminergic neurons in Parkinson's disease.

Journal: Acta biomaterialia
Published: November 05, 2025

Electromagnetized MXenes Enhance the Efficient Direct Reprogramming of Dopamine Neurons for Parkinson's Disease Therapy.

Electromagnetized MXenes Enhance the Efficient Direct Reprogramming of Dopamine Neurons for Parkinson's Disease Therapy.

Journal: ACS nano
Published: April 21, 2025

Aberrant neural stem cell quiescence is the gateway to autism development linked to Arid1b.

Aberrant neural stem cell quiescence is the gateway to autism development linked to Arid1b.

Journal: Molecular psychiatry
Published: July 02, 2024

Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease.

Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 25, 2024

Electromagnetic field-inducible in vivo gene switch for remote spatiotemporal control of gene expression.

Electromagnetic field-inducible in vivo gene switch for remote spatiotemporal control of gene expression.

Journal: Cell
Published: July 25, 2023

Transcriptional activation of endogenous Oct4 via the CRISPR/dCas9 activator ameliorates Hutchinson-Gilford progeria syndrome in mice.

Transcriptional activation of endogenous Oct4 via the CRISPR/dCas9 activator ameliorates Hutchinson-Gilford progeria syndrome in mice.

Journal: Aging cell
Published: June 15, 2022

Transcriptional activation with Cas9 activator nanocomplexes rescues Alzheimer's disease pathology.

Transcriptional activation with Cas9 activator nanocomplexes rescues Alzheimer's disease pathology.

Journal: Biomaterials
Published: June 13, 2021
Showing 1-9 of 9

Last Updated: 09/26/2026